Senate Finance Committee Chairman Ron Wyden (D-Ore.) has released a set of drug pricing principles that will likely be folded into the Democrat’s upcoming multi-trillion tax and spend reconciliation legislation. Wyden’s plan includes a number of concerning proposals including the imposition of price controls on Medicare Part D under the guise of “negotiation.”
Read more: Lawmakers Should Reject Government “Negotiation” in Medicare Part D
